BCG Tuberculosis (TB) Vaccine Market Report

Global and China BCG Tuberculosis (TB) Vaccine Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 24, 2022
  • PAGES：160
  • REPORT CODE：GMM1491412
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the BCG Tuberculosis (TB) Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Japan BCG Lab

    • Intervax

    • Sanofi Pasteur

    • China National Biotec

    • GSBPL

    • Merck

    • Serum Institute of India

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Immune BCG

    • Therapy BCG

    Application:

    • Hospital

    • Clinic

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 BCG Tuberculosis (TB) Vaccine Industry Overview

      • 1.1.1 BCG Tuberculosis (TB) Vaccine Market Scope and Market Segments

      • 1.1.2 BCG Tuberculosis (TB) Vaccine Industry Characteristics

      • 1.1.3 Global and China BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China BCG Tuberculosis (TB) Vaccine Production Value and Growth Rate (2017-2028)

    • 1.2 Global BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Immune BCG

      • 1.2.2 Therapy BCG

    • 1.3 Global BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinic

    • 1.4 Market Analysis by Region

      • 1.4.1 North America BCG Tuberculosis (TB) Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe BCG Tuberculosis (TB) Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC BCG Tuberculosis (TB) Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global BCG Tuberculosis (TB) Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global BCG Tuberculosis (TB) Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China BCG Tuberculosis (TB) Vaccine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China BCG Tuberculosis (TB) Vaccine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global BCG Tuberculosis (TB) Vaccine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 BCG Tuberculosis (TB) Vaccine Industry Porter's Five Forces Model Analysis

      • 2.2.3 BCG Tuberculosis (TB) Vaccine Industry PEST Analysis

    • 2.3 BCG Tuberculosis (TB) Vaccine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 BCG Tuberculosis (TB) Vaccine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on BCG Tuberculosis (TB) Vaccine Industry

    Chapter 3 Global and China BCG Tuberculosis (TB) Vaccine Market, by Manufacturer

    • 3.1 Global and China BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China BCG Tuberculosis (TB) Vaccine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China BCG Tuberculosis (TB) Vaccine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China BCG Tuberculosis (TB) Vaccine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China BCG Tuberculosis (TB) Vaccine Market Top 3 Players

    Chapter 4 Global and China BCG Tuberculosis (TB) Vaccine Market, by Type (2017-2028)

    • 4.1 BCG Tuberculosis (TB) Vaccine Market Trend, by Type

    • 4.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global BCG Tuberculosis (TB) Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global BCG Tuberculosis (TB) Vaccine Price Trend, by Type (2017-2028)

    • 4.3 China BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China BCG Tuberculosis (TB) Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China BCG Tuberculosis (TB) Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China BCG Tuberculosis (TB) Vaccine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China BCG Tuberculosis (TB) Vaccine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global BCG Tuberculosis (TB) Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China BCG Tuberculosis (TB) Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China BCG Tuberculosis (TB) Vaccine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America BCG Tuberculosis (TB) Vaccine Market Analysis

    • 7.1 North America BCG Tuberculosis (TB) Vaccine Market, by Type

    • 7.2 North America BCG Tuberculosis (TB) Vaccine Market, by Application

    • 7.3 North America BCG Tuberculosis (TB) Vaccine Market Analysis and Forecast, by Country

      • 7.3.1 United States BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe BCG Tuberculosis (TB) Vaccine Market Analysis

    • 8.1 Europe BCG Tuberculosis (TB) Vaccine Market, by Type

    • 8.2 Europe BCG Tuberculosis (TB) Vaccine Market, by Application

    • 8.3 Europe BCG Tuberculosis (TB) Vaccine Market Analysis and Forecast, by Country

      • 8.3.1 Germany BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC BCG Tuberculosis (TB) Vaccine Market Analysis

    • 9.1 APAC BCG Tuberculosis (TB) Vaccine Market, by Type

    • 9.2 APAC BCG Tuberculosis (TB) Vaccine Market, by Application

    • 9.3 APAC BCG Tuberculosis (TB) Vaccine Market Analysis and Forecast, by Country

      • 9.3.1 China BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Analysis

    • 10.1 Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Market, by Type

    • 10.2 Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Market, by Application

    • 10.3 Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina BCG Tuberculosis (TB) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China BCG Tuberculosis (TB) Vaccine Company Profiles

      • 11.1 Japan BCG Lab

        • 11.1.1 Japan BCG Lab Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Profiles, Application and Specification

        • 11.1.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Intervax

        • 11.2.1 Intervax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Intervax BCG Tuberculosis (TB) Vaccine Product Profiles, Application and Specification

        • 11.2.3 Intervax BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Sanofi Pasteur

        • 11.3.1 Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Profiles, Application and Specification

        • 11.3.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 China National Biotec

        • 11.4.1 China National Biotec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 China National Biotec BCG Tuberculosis (TB) Vaccine Product Profiles, Application and Specification

        • 11.4.3 China National Biotec BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 GSBPL

        • 11.5.1 GSBPL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 GSBPL BCG Tuberculosis (TB) Vaccine Product Profiles, Application and Specification

        • 11.5.3 GSBPL BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Merck

        • 11.6.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Merck BCG Tuberculosis (TB) Vaccine Product Profiles, Application and Specification

        • 11.6.3 Merck BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Serum Institute of India

        • 11.7.1 Serum Institute of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Profiles, Application and Specification

        • 11.7.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 BCG Tuberculosis (TB) Vaccine Industry Investment Prospect and Risk Assessment

    • 12.1 BCG Tuberculosis (TB) Vaccine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 BCG Tuberculosis (TB) Vaccine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Global BCG Tuberculosis (TB) Vaccine Production Value and Growth Rate (2017-2028)

    • Figure China BCG Tuberculosis (TB) Vaccine Production Value and Growth Rate (2017-2028)

    • Figure Global BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Immune BCG (2017-2028)

    • Figure Global BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Therapy BCG (2017-2028)

    • Figure Global BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Clinic (2017-2028)

    • Figure North America BCG Tuberculosis (TB) Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe BCG Tuberculosis (TB) Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC BCG Tuberculosis (TB) Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global BCG Tuberculosis (TB) Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China BCG Tuberculosis (TB) Vaccine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China BCG Tuberculosis (TB) Vaccine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China BCG Tuberculosis (TB) Vaccine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China BCG Tuberculosis (TB) Vaccine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China BCG Tuberculosis (TB) Vaccine Market Share, by Manufacturer in 2021

    • Figure Global and China BCG Tuberculosis (TB) Vaccine Market Share, by Manufacturer in 2022

    • Table Global BCG Tuberculosis (TB) Vaccine Sales Volume, by Type (2017-2028)

    • Table Global BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Global BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Global BCG Tuberculosis (TB) Vaccine Sales Value, by Type (2017-2028)

    • Table Global BCG Tuberculosis (TB) Vaccine Sales Value Share, by Type (2017-2028)

    • Figure Global BCG Tuberculosis (TB) Vaccine Price Trend, by Type (2017-2028)

    • Table China BCG Tuberculosis (TB) Vaccine Sales Volume, by Type (2017-2028)

    • Table China BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure China BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table China BCG Tuberculosis (TB) Vaccine Sales Value, by Type (2017-2028)

    • Table China BCG Tuberculosis (TB) Vaccine Sales Value Share, by Type (2017-2028)

    • Figure China BCG Tuberculosis (TB) Vaccine Price Trend, by Type (2017-2028)

    • Table Global BCG Tuberculosis (TB) Vaccine Sales Volume, by Application (2017-2028)

    • Table Global BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Global BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Table Global BCG Tuberculosis (TB) Vaccine Sales Value, by Application (2017-2028)

    • Table Global BCG Tuberculosis (TB) Vaccine Sales Value Share, by Application (2017-2028)

    • Figure Global BCG Tuberculosis (TB) Vaccine Sales Value Share, by Application (2017-2028)

    • Table China BCG Tuberculosis (TB) Vaccine Sales Volume, by Application (2017-2028)

    • Table China BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Table China BCG Tuberculosis (TB) Vaccine Sales Value, by Application (2017-2028)

    • Table China BCG Tuberculosis (TB) Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China BCG Tuberculosis (TB) Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure North America BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export (2017-2022)

    • Table North America BCG Tuberculosis (TB) Vaccine Sales Volume, by Type (2017-2028)

    • Table North America BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure North America BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table North America BCG Tuberculosis (TB) Vaccine Sales Volume, by Application (2017-2028)

    • Table North America BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure North America BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure United States BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure United States BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Canada BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Europe BCG Tuberculosis (TB) Vaccine Sales Volume, by Type (2017-2028)

    • Table Europe BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Europe BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Europe BCG Tuberculosis (TB) Vaccine Sales Volume, by Application (2017-2028)

    • Table Europe BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Europe BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Germany BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure UK BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure UK BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure France BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure France BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Italy BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Spain BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Poland BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Russia BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Table APAC BCG Tuberculosis (TB) Vaccine Sales Volume, by Type (2017-2028)

    • Table APAC BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure APAC BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table APAC BCG Tuberculosis (TB) Vaccine Sales Volume, by Application (2017-2028)

    • Table APAC BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure APAC BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Japan BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure India BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure India BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina BCG Tuberculosis (TB) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina BCG Tuberculosis (TB) Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Japan BCG Lab Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Japan BCG Lab Product Profiles, Application and Specification

    • Table Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Intervax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Intervax Product Profiles, Application and Specification

    • Table Intervax BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Pasteur Product Profiles, Application and Specification

    • Table Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table China National Biotec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table China National Biotec Product Profiles, Application and Specification

    • Table China National Biotec BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GSBPL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSBPL Product Profiles, Application and Specification

    • Table GSBPL BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Serum Institute of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Serum Institute of India Product Profiles, Application and Specification

    • Table Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US